Figures computed from official regulatory filings — .
Analysttarget 73 USD (-5%) · consensus 5/5 · 4 buy · 0 hold · 0 sell
Ownershipinsiders 1.64% · institutions 96.65% · short 7.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Forte Biosciences, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
31 buys3 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Wagner Paul A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kornfeld Steven | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Wagner Paul A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| FINCK BARBARA K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kapoor Shivpreet Singh | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Riley Anthony Atrack record | Other | n/a (No price was disclosed in the filing) | SEC |
| VINCENT RICHARD G | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Brun Scott C. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Wagner Paul A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Riley Anthony Atrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kapoor Shivpreet Singh | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Wagner Paul A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| FINCK BARBARA K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Brun Scott C. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Wagner Paul A.track record | Other | n/a (No price was disclosed in the filing) | SEC |
| Riley Anthony Atrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kapoor Shivpreet Singh | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Wagner Paul A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| GRYSKA DAVID W | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Doberstein Stephen K | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |